Sign in
4

Changes in Ownership

TScan Therapeutics, Inc. Filed Acc 0001193125-26-019723

Options or other derivatives

  • Chief Executive Officer acquired 1,165,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

MacBeath Gavin · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-20 Grant or award : show line 1 in the form Stock Option (Right to Buy) +1,165,000 1,165,000 D
Loading xslF345X05/ownership.xml…